| Cancer history and melanoma risk |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Dec 13, 2012 |
PLCO-10 |
| Analysis of PSA, biopsy uptake predictive value and associated death in a prostate cancer screening programme |
Mathieu Boniol |
International Prevention Research Institute |
PLCO |
Dec 11, 2012 |
PLCO-8 |
| Reconciling results of PSA screening efficacy using PLCO and ERSPC data: CISNET modeling project |
Ruth Etzioni |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 11, 2012 |
PLCO-9 |
| Implications of Prevalence CT scan Findings on Future Lung Cancer Risk |
david wilson |
University of Pittsburgh |
NLST |
Dec 10, 2012 |
NLST-5 |
| BMI and risks of pancreatic cancer and multiple myeloma mortality in the African American BMI Pooling Project |
Cari Kitahara |
NCI, DCEG, NEB |
PLCO |
Dec 7, 2012 |
PLCO-7 |
| The Cancer Risk Management Lung Cancer Model |
Anthony Miller |
University of Toronto |
NLST |
Dec 7, 2012 |
NLST-4 |
| Validation of a Risk Assessment Decision Rule for Epithelial Ovarian Cancer |
Nicole Urban |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 3, 2012 |
PLCO-6 |
| Supporting NLST Investigator Use of Query Tool (QT) |
Fred Prior |
University of Arkansas for Medical Sciences |
NLST |
Nov 26, 2012 |
NLST-3 |
| Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to thyroid cancer risk in the PLCO study |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-5 |
| Demographic, lifestyle, reproductive, and hormonal factors, medical history, and medication use in relation to glioma in the PLCO study |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-4 |
| Benign breast and reproductive conditions and thyroid cancer |
Melissa Braganza |
NCI, DCEG, REB |
PLCO |
Nov 20, 2012 |
PLCO-2 |
| Lung Cancer Diagnosed Following a Negative CT Screening Examination |
David Gierada |
Washington University |
NLST |
Nov 15, 2012 |
NLST-1 |
| follow-up of abnormal CA 125 levels in patients in the PLCO trial |
Keith Terada |
University of Hawaii |
PLCO |
Nov 14, 2012 |
PLCO-3 |
| Thyroid Cancer and NSAIDs: A Pooled Analysis |
Naris Nilubol |
NCI, CCR, EOB |
PLCO |
Nov 2, 2012 |
PLCO-1 |
| Validation of Biomarker Panel for Classification of Indeterminate Pulmonary Nodules |
Charles Birse |
Celera |
PLCO |
Oct 23, 2012 |
2012-0222 |
| Circulating inflammation markers and risk of lung cancer: A replication study |
Meredith Shiels |
NCI |
PLCO |
Oct 22, 2012 |
2012-0356 |
| Expression levels and prostate cancer recurrence in PLCO |
Michael Cook |
NCI |
PLCO |
Oct 22, 2012 |
2012-0312 |
| Validation of protein biomarker signatures of prostate cancer aggressiveness |
Stephen Schmechel |
University of Minnesota |
PLCO |
Oct 22, 2012 |
2012-0286 |
| Epigenetic Variation at 8q24 and Prostate Cancer Risk |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Oct 22, 2012 |
2012-0282 |
| Blood-based gene expression markers for early detection of lung cancer |
Melissa Rotunno |
NCI, DCEG, GEB |
PLCO |
Oct 22, 2012 |
2012-0247 |
